Bedrocan products in Australia are only available through the Therapeutic Goods Administration (TGA) Special Access Scheme (Cat B) or through the Authorised Prescriber scheme. Novachem can not provide medicinal cannabis products to individuals under any circumstances.
Patients wishing to access medicinal cannabis products should discuss access with their physician and make themselves familiar with the processes by reading the TGA advice at www.tga.gov.au/access-medicinal-cannabis-products. Novachem is only able to supply pharmacies with Bedrocan Medicinal Cannabis products once the TGA has authorised the access and all approval documents have been provided to and verified by Novachem.
The TGA administer the Special Access Scheme (SAS) and Authorised Prescriber Scheme which allow eligible medical practitioners to apply for the importation and supply of medicinal cannabis products that are not registered on the Australian Register of Therapeutic Goods (ARTG):